Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
1 file | 32.05 KB
Add to list
  1. Search results
  2. Novel medicines can be cheaper

Novel medicines can be cheaper

Frank Roels (UGent)
(2022) JOURNAL OF INHERITED METABOLIC DISEASE. In Journal of Inherited Metabolic Disease 45(Supplement 1). p.254-254
Author
Organization
Abstract
List of prices of expensive medicines for inherited metabolic diseases and for cancer. Consequences of high pricing. List of billions net profits of pharmaceutical companies, dividends, and corporate taxes paid in 2021. Alternatives. Discussion.
Keywords
Johnson&Johnson, Pfizer, GSK, AbbVie, Sanofi, Gilead, Novartis, Roche, Merck, NovoNordisk, Biogen, EliLilly, AstraZeneca, Vertex

Downloads

  • Download
    NOVEL MEDICINES POSTER 27.pptx
    • supplementary material
    • |
    • open access
    • |
    • PowerPoint
    • |
    • 32.05 KB

Citation

Please use this url to cite or link to this publication:

MLA
Roels, Frank. “Novel Medicines Can Be Cheaper.” JOURNAL OF INHERITED METABOLIC DISEASE, vol. 45, no. Supplement 1, Wiley, 2022, pp. 254–254.
APA
Roels, F. (2022). Novel medicines can be cheaper. JOURNAL OF INHERITED METABOLIC DISEASE, 45(Supplement 1), 254–254. Wiley.
Chicago author-date
Roels, Frank. 2022. “Novel Medicines Can Be Cheaper.” In JOURNAL OF INHERITED METABOLIC DISEASE, 45:254–254. Wiley.
Chicago author-date (all authors)
Roels, Frank. 2022. “Novel Medicines Can Be Cheaper.” In JOURNAL OF INHERITED METABOLIC DISEASE, 45:254–254. Wiley.
Vancouver
1.
Roels F. Novel medicines can be cheaper. In: JOURNAL OF INHERITED METABOLIC DISEASE. Wiley; 2022. p. 254–254.
IEEE
[1]
F. Roels, “Novel medicines can be cheaper,” in JOURNAL OF INHERITED METABOLIC DISEASE, Freiburg, Germany, 2022, vol. 45, no. Supplement 1, pp. 254–254.
@inproceedings{8766768,
  abstract     = {{List of prices of expensive medicines for inherited metabolic diseases and for cancer. Consequences of high pricing. List of billions net profits of pharmaceutical companies, dividends, and corporate taxes paid in 2021. Alternatives. Discussion.}},
  articleno    = {{2123}},
  author       = {{Roels, Frank}},
  booktitle    = {{JOURNAL OF INHERITED METABOLIC DISEASE}},
  issn         = {{0141-8955}},
  keywords     = {{Johnson&Johnson,Pfizer,GSK,AbbVie,Sanofi,Gilead,Novartis,Roche,Merck,NovoNordisk,Biogen,EliLilly,AstraZeneca,Vertex}},
  language     = {{eng}},
  location     = {{Freiburg, Germany}},
  number       = {{Supplement 1}},
  pages        = {{2123:254--2123:254}},
  publisher    = {{Wiley}},
  title        = {{Novel medicines can be cheaper}},
  url          = {{https://onlinelibrary.wiley.com/doi/epdf/10.1002/jimd.12536}},
  volume       = {{45}},
  year         = {{2022}},
}